Clinical Trial Update: Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on mesenchymal stromal cells for treating atrophic nonunion fractures of long bones (Phase 1/Phase 2) have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Nonunion of Fracture
• Long Bone Nonunion

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Banc de Sang i Teixits | Conditions: Atrophic Nonunion of Fracture | Phase 1, Phase 2 | Status: COMPLETED